
John Cruz
Faculty peer reviewed
A number of studies have shown that zolpidem (Ambien), the most commonly prescribed sleep-inducing medication on the market, can produce uncontrollable nocturnal eating …

John Cruz
Faculty peer reviewed
A number of studies have shown that zolpidem (Ambien), the most commonly prescribed sleep-inducing medication on the market, can produce uncontrollable nocturnal eating …
Kanika Ballani, Pharm.D.
Diana Hubulasvili, Pharm.D.
 Developed by Amylin Pharmaceuticals, Exenatide (Byetta®) is an incretin mimetic that is used as an adjunctive therapy with metformin, a sulfonylurea or a thiazolidinedione to improve glycemic …

Frederick Gandolfo, MD
Case: An 85 year-old woman admitted to the hospital with pneumonia and after a prolonged hospital course developed heparin-induced thrombocytopenia (HIT). She …

Commentary by Adi Diab MD, PGY-3
This past week on January 21th, Medical Grand Rounds was given by guest speaker Dr. John Griffin who shared his knowledge of the role of Activate …
Commentary by Rachana Jani MD, PGY-2
As recently reported in ShortCuts, Byetta recently made headlines after the suggestion of a mortality benefit for patients taking the drug in a small subset of the Accord study. So is this the new golden …
Commentary by Marilena S. Antonopoulos Pharm.D, Pharmacology Section Editor
Until recently, drugs safety alerts (aka “Dear Doctor lettersâ€) were sent out to physicians through traditional U.S. mail, a slow and error-prone process. These alerts …
Commentary by Marilena S. Antonopoulos, PharmD, Pharmacology Editor
On July 8th, the FDA notified the manufacturers of fluoroquinolone antimicrobial drugs that a Boxed Warning in the product labeling and a Medication Guide …
Commentary by Melissa Freeman, PGY-2Â
As summertime is just around the corner, many begin to evaluate whether their bodies are ready to expose what has been hidden under those bulky winter clothes. Between …